Caspofungin in a pediatric patient with persistent candidemia

Karin K. Wertz, Robert K. Pretzlaff

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: To describe the response of a child with persistent fungemia to caspofungin, a member of the echinocandin class of antifungals. Design: Descriptive case report. Setting: Pediatric intensive care unit at a university teaching hospital. Patient: A 3-yr-old female with persistent candidemia. Intervention: After >5 wks of persistent candidemia, caspofungin was added to an antifungal regimen that included amphotericin B and flucytosine. Measurements and Main Results: The addition of caspofungin resulted in rapid clearance of the candidemia. The child recovered without evidence of further fungal infection or overt toxicity. Conclusion: Caspofungin was administered safely in this pediatric patient and possibly contributed to her clinical improvement. Caspofungin may be considered in children with severe persistent fungal infections that are not responsive to standard therapy. More study in pediatric patients is necessary before recommending its general use.

Original languageEnglish (US)
Pages (from-to)181-183
Number of pages3
JournalPediatric Critical Care Medicine
Volume5
Issue number2
DOIs
StatePublished - 2004

Fingerprint

caspofungin
Candidemia
Pediatrics
Mycoses
Echinocandins
Fungemia
Flucytosine
Pediatric Intensive Care Units
Amphotericin B
Teaching Hospitals

Keywords

  • Antifungal
  • Candidemia
  • Caspofungin
  • Child

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Critical Care and Intensive Care Medicine

Cite this

Caspofungin in a pediatric patient with persistent candidemia. / Wertz, Karin K.; Pretzlaff, Robert K.

In: Pediatric Critical Care Medicine, Vol. 5, No. 2, 2004, p. 181-183.

Research output: Contribution to journalArticle

Wertz, Karin K. ; Pretzlaff, Robert K. / Caspofungin in a pediatric patient with persistent candidemia. In: Pediatric Critical Care Medicine. 2004 ; Vol. 5, No. 2. pp. 181-183.
@article{e395a9a360554343afd358c71177e30e,
title = "Caspofungin in a pediatric patient with persistent candidemia",
abstract = "Objective: To describe the response of a child with persistent fungemia to caspofungin, a member of the echinocandin class of antifungals. Design: Descriptive case report. Setting: Pediatric intensive care unit at a university teaching hospital. Patient: A 3-yr-old female with persistent candidemia. Intervention: After >5 wks of persistent candidemia, caspofungin was added to an antifungal regimen that included amphotericin B and flucytosine. Measurements and Main Results: The addition of caspofungin resulted in rapid clearance of the candidemia. The child recovered without evidence of further fungal infection or overt toxicity. Conclusion: Caspofungin was administered safely in this pediatric patient and possibly contributed to her clinical improvement. Caspofungin may be considered in children with severe persistent fungal infections that are not responsive to standard therapy. More study in pediatric patients is necessary before recommending its general use.",
keywords = "Antifungal, Candidemia, Caspofungin, Child",
author = "Wertz, {Karin K.} and Pretzlaff, {Robert K.}",
year = "2004",
doi = "10.1097/01.PCC.0000113264.00053.AF",
language = "English (US)",
volume = "5",
pages = "181--183",
journal = "Pediatric Critical Care Medicine",
issn = "1529-7535",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Caspofungin in a pediatric patient with persistent candidemia

AU - Wertz, Karin K.

AU - Pretzlaff, Robert K.

PY - 2004

Y1 - 2004

N2 - Objective: To describe the response of a child with persistent fungemia to caspofungin, a member of the echinocandin class of antifungals. Design: Descriptive case report. Setting: Pediatric intensive care unit at a university teaching hospital. Patient: A 3-yr-old female with persistent candidemia. Intervention: After >5 wks of persistent candidemia, caspofungin was added to an antifungal regimen that included amphotericin B and flucytosine. Measurements and Main Results: The addition of caspofungin resulted in rapid clearance of the candidemia. The child recovered without evidence of further fungal infection or overt toxicity. Conclusion: Caspofungin was administered safely in this pediatric patient and possibly contributed to her clinical improvement. Caspofungin may be considered in children with severe persistent fungal infections that are not responsive to standard therapy. More study in pediatric patients is necessary before recommending its general use.

AB - Objective: To describe the response of a child with persistent fungemia to caspofungin, a member of the echinocandin class of antifungals. Design: Descriptive case report. Setting: Pediatric intensive care unit at a university teaching hospital. Patient: A 3-yr-old female with persistent candidemia. Intervention: After >5 wks of persistent candidemia, caspofungin was added to an antifungal regimen that included amphotericin B and flucytosine. Measurements and Main Results: The addition of caspofungin resulted in rapid clearance of the candidemia. The child recovered without evidence of further fungal infection or overt toxicity. Conclusion: Caspofungin was administered safely in this pediatric patient and possibly contributed to her clinical improvement. Caspofungin may be considered in children with severe persistent fungal infections that are not responsive to standard therapy. More study in pediatric patients is necessary before recommending its general use.

KW - Antifungal

KW - Candidemia

KW - Caspofungin

KW - Child

UR - http://www.scopus.com/inward/record.url?scp=3843086366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843086366&partnerID=8YFLogxK

U2 - 10.1097/01.PCC.0000113264.00053.AF

DO - 10.1097/01.PCC.0000113264.00053.AF

M3 - Article

C2 - 14987350

AN - SCOPUS:3843086366

VL - 5

SP - 181

EP - 183

JO - Pediatric Critical Care Medicine

JF - Pediatric Critical Care Medicine

SN - 1529-7535

IS - 2

ER -